| Literature DB >> 20670888 |
Tomohiro Nakamura1, Lei Wang, Catherine C L Wong, Fiona L Scott, Brendan P Eckelman, Xuemei Han, Christos Tzitzilonis, Fanjun Meng, Zezong Gu, Emily A Holland, Arjay T Clemente, Shu-ichi Okamoto, Guy S Salvesen, Roland Riek, John R Yates, Stuart A Lipton.
Abstract
X-linked inhibitor of apoptosis (XIAP) is a potent antagonist of caspase apoptotic activity. XIAP also functions as an E3 ubiquitin ligase, targeting caspases for degradation. However, molecular pathways controlling XIAP activities remain unclear. Here, we report that nitric oxide (NO) reacts with XIAP by S-nitrosylating its RING domain (forming SNO-XIAP), thereby inhibiting E3 ligase and antiapoptotic activity. NO-mediated neurotoxicity and caspase activation have been linked to several neurodegenerative disorders, including Alzheimer's, Parkinson's, and Huntington's diseases. We find significant SNO-XIAP formation in brains of patients with these diseases, implicating this reaction in the etiology of neuronal damage. Conversely, S-nitrosylation of caspases is known to inhibit apoptotic activity. Unexpectedly, we find that SNO-caspase transnitrosylates (transfers its NO group) to XIAP, forming SNO-XIAP, and thus promotes cell injury and death. These findings provide insights into the regulation of caspase activation in neurodegenerative disorders mediated, at least in part, by nitrosative stress. Copyright 2010 Elsevier Inc. All rights reserved.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20670888 PMCID: PMC2924818 DOI: 10.1016/j.molcel.2010.07.002
Source DB: PubMed Journal: Mol Cell ISSN: 1097-2765 Impact factor: 17.970